|
1
|
Siegel RL, Kratzer TB, Giaquinto AN, Sung
H and Jemal A: . Cancer statistics, 2025. CA Cancer J Clin.
75:10–45. 2025.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Han B, Zheng R, Zeng H, Wang S, Sun K,
Chen R, Li L, Wei W and He J: Cancer incidence and mortality in
China, 2022. J Natl Cancer Cent. 4:47–53. 2024.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Siegel RL, Miller KD, Wagle NS and Jemal
A: Cancer statistics, 2023. A Cancer J Clin. 73:17–48.
2023.PubMed/NCBI View Article : Google Scholar
|
|
4
|
World Obesity Federation: World Obesity
Atlas 2024. World Obesity Federation, London, 2024.
|
|
5
|
García-Estévez L, González-Rodríguez M,
Calvo I, Orta A, Gión M, Moreno-Bueno G, Pérez-García JM and Cortés
J: Obesity, overweight and breast cancer: New clinical data and
implications for practice. Front Oncol. 15(1579876)2025.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lagarde CB, Kavalakatt J, Benz MC, Hawes
ML, Arbogast CA, Cullen NM, McConnell EC, Rinderle C, Hebert KL,
Khosla M, et al: Obesity-associated epigenetic alterations and the
obesity-breast cancer axis. Oncogene. 43:763–755. 2024.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Jiralerspong S and Goodwin PJ: Obesity and
breast cancer prognosis: Evidence, challenges, and opportunities. J
Clin Oncol. 34:4203–4216. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Glassman I, Le N, Asif A, Goulding A,
Alcantara CA, Vu A, Chorbajian A, Mirhosseini M, Singh M and
Venketaraman V: The role of obesity in breast cancer pathogenesis.
Cells. 12(2061)2023.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Bertozzi S, Londero AP, Diaz Nanez JA, Di
Vora R, Baita B, La Verghetta L, Prada S, Seriau L, Mariuzzi L and
Cedolini C: Breast cancer care for the aging population: A focus on
age-related disparities in breast cancer treatment. BMC Cancer.
25(492)2025.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Svanøe AA, Humlevik ROC, Knutsvik G, Sæle
AKM, Askeland C, Ingebriktsen LM, Hugaas U, Kvamme AB, Tegnander
AF, Krüger K, et al: Age-related phenotypes in breast cancer: A
population-based study. Int J Cancer. 154:2014–2024.
2024.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Friedman JM: Leptin and the endocrine
control of energy balance. Nat Metab. 1:754–764. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Suzuki Y, Tsunoda H, Kimura T and Yamauchi
H: BMI change and abdominal circumference are risk factors for
breast cancer, even in Asian women. Breast Cancer Res Treat.
166:919–925. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Bhaskaran K, Douglas I, Forbes H,
dos-Santos-Silva I, Leon DA and Smeeth L: Body-mass index and risk
of 22 specific cancers: A population-based cohort study of 5·24
million UK adults. Lancet. 384:755–765. 2024.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Renehan AG, Tyson M, Egger M, Heller RF
and Zwahlen M: Body-mass index and incidence of cancer: A
systematic review and meta-analysis of prospective observational
studies. Lancet. 371:569–578. 2008.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wang X, Li L, Gao J, Liu J, Guo M, Liu L,
Wang W, Wang J, Xing Z, Yu Z and Wang X: The association between
body sizeand breast cancer in han women in northern and eastern
China. Oncologist. 21:1362–1368. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Lim U, Ernst T, Buchthal SD, Latch M,
Albright CL, Wilkens LR, Kolonel LN, Murphy SP, Chang L, Novotny R
and Le Marchand L: Asian women have greater abdominal and visceral
adiposity than Caucasian women with similar body mass index. Nutr
Diabetes. 1(e6)2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Choi E, Lee JK, Baek JK, Chung Y, Kim H,
Yun BH and Seo SK: Hormone replacement therapy and breast cancer
incidence in Korean women. Maturitas. 183(107946)2024.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wei Y, Lv J, Guo Y, Bian Z, Gao M, Du H,
Yang L, Chen Y, Zhang X, Wang T, et al: Soy intake and breast
cancer risk: A prospective study of 300,000 Chinese women and a
dose-response meta-analysis. Eur J Epidemiol. 35:567–578.
2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
WHO Expert Consultation. Appropriate
body-mass index for Asian populations and its implications for
policy and intervention strategies. Lancet. 363:157–163.
2004.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Tehard B and Clavel-Chapelon F: Several
anthropometric measurements and breast cancerrisk: Results of the
E3N cohort study. Int J Obes (Lond). 30:156–163. 2006.
|
|
21
|
Houghton SC, Eliassen H, Tamimi RM,
Willett WC, Rosner BA and Hankinson SE: Central adiposity and
subsequent riskof breast cancer by menopause status. J Natl Cancer
Inst. 113:900–908. 2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
John EM, Sangaramoorthy M, Hines LM, Stern
MC, Baumgartner KB, Giuliano AR, Wolff RK and Slattery ML: Overall
and abdominal adiposity and premenopausal breast cancer risk among
hispanic women: The breast cancer health disparities study. Cancer
Epidemiol Biomarkers Prev. 24:138–147. 2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Nindrea RD, Aryandono T, Lazuardi L and
Dwiprahasto I: Association of overweight and obesity with breast
cancer during premenopausal period in Asia: A meta-analysis. Int J
Prev Med. 10(192)2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wassef H, Bissonnette S, Dufour R,
Davignon J and Faraj M: Enrichment of triglyceride-rich
lipoproteins with apolipoprotein C-I is positively associated with
their delayed plasma clearance independently of other transferable
apolipoproteins in postmenopausal overweight and obese women. J
Nutr. 147:754–762. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ye Y, Sun X and Lu Y: Obesity-related
fatty acid and cholesterol metabolism in cancer-associated host
cells. Front Cell Dev Biol. 8(600350)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Baek AE, Krawczynska N, Das Gupta A,
Dvoretskiy SV, You S, Park J, Deng YH, Sorrells JE, Smith BP, Ma L,
et al: The cholesterol metabolite 27HC increases secretion of
extracellular vesicles which promote breast cancer progression.
Endocrinology. 162(bqab095)2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Avena P, Casaburi I, Zavaglia L, Nocito
MC, La Padula D, Rago V, Dong J, Thomas P, Mineo C, Sirianni R and
Shaul PW: 27-Hydroxycholesterol binds GPER and induces progression
of estrogen receptor-negative breast cancer. Cancers (Basel).
14(1521)2022.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yee LD, Mortimer JE, Natarajan R, Dietze
EC and Seewaldt VL: Metabolic health, insulin, and breast cancer:
Why oncologists should care about insulin. Front Endocrinol
(Lausanne). 11(58)2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Huang YK, Kang WM, Ma ZQ, Liu YQ, Zhou L
and Yu JC: NUCKS1 promotes gastric cancer cell aggressiveness by
upregulating IGF-1R and subsequently activating the PI3K/Akt/mTOR
signaling pathway. Carcinogenesis. 40:370–379. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Pollak M: Insulin and insulin-like growth
factor signalling in neoplasia. Nat Rev Cancer. 8:915–928.
2008.PubMed/NCBI View
Article : Google Scholar
|
|
31
|
Alves CL and Ditzel HJ: Drugging the
PI3K/AKT/mTOR pathway in ER+ breast bancer. Int J Mol Sci.
24(5)(4522)2023.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Fruman DA, Chiu H, Hopkins BD, Bagrodia S,
Cantley LC and Abraham RT: The PI3K pathway in human disease. Cell.
170:605–635. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kabat GC, Kim MY, Ho GY, et al: Serum
insulin, C-peptide and breast-cancer risk: A nested case-control
study in the WHI. Cancer Epidemiol Biomark Prev. 29:1783–1790.
2020.
|
|
34
|
Albers FEM, Swain CTV, Lou MWC, Dashti SG,
Rinaldi S, Viallon V, Karahalios A, Brown KA, Gunter MJ, et al:
Insulin and insulin-like growth factor and risk of postmenopausal
estrogen receptor-positive breast cancer: A case-cohort analysis.
Cancer Epidemiol Biomarkers Prev. 34(4):541–549. 2025.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Knuppel A, Fensom GK, Watts EL, Gunter MJ,
Murphy N, Papier K, Perez-Cornago A, Schmidt JA, Smith Byrne K, et
al: Circulating insulin-like growth factor-I concentrations and
risk of 30 cancers: Prospective analyses in UK biobank. Cancer Res.
80(18):4014–4021. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Howe LR, Subbaramaiah K, Hudis CA and
Dannenberg AJ: Molecular pathways: Adipose inflammation as a
mediator of obesity-associated cancer. Clin Cancer Res.
19:6074–6083. 2013.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Gallagher EJ and LeRoith D: Obesity and
diabetes: The increased risk of cancer and cancer-related
mortality. Physiol Rev. 95:727–748. 2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Dalamaga M: Obesity, insulin resistance,
adipocytokines and breast cancer: New biomarkers and attractive
therapeutic targets. World J Exp Med. 3:34–42. 2013.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Chen YZ, Liu L, Zhou Q, Imam MU, Cai J,
Wang Y, Qi M, Sun P, Ping Z and Fu X: Body mass index had different
effects on premenopausal and postmenopausal breast cancer risks: A
dose-response meta-analysis with 3,318,796 subjects from 31 cohort
studies. BMC Public Health. 17(936)2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Monteiro M, Zhang X and Yee D: Insulin
promotes growth in breast cancer cells through the type I IGF
receptor in insulin receptor deficient cells. Exp Cell Res.
434(113862)2024.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Albers FEM, Swain CTV, Lou MWC, Dashti SG,
Rinaldi S, Viallon V, Karahalios A, Brown KA, Gunter MJ, Milne RL,
et al: Insulin and insulin-like growth factor and risk of
postmenopausal estrogen receptor-positive breast cancer: A
case-cohort analysis. Cancer Epidemiol Biomarkers Prev. 34:541–549.
2025.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Zhang X, Varma S and Yee D: Suppression of
insulin receptor substrate 1 inhibits breast cancer growth in vitro
and in female athymic mice. Endocrinology.
164(bqac214)2023.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Saha T, Makar S, Swetha R, Gutti G and
Singh SK: Estrogen signaling: An emanating therapeutic target for
breast cancer treatment. Eur J Med Chem. 177:116–143.
2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Olea-Flores M, Juárez-Cruz JC,
Mendoza-Catalán MA, Padilla-Benavides T and Navarro-Tito N:
Signaling pathways induced by leptin during epithelial-mesenchymal
transition in breast cancer. Int J Mol Sci. 19(3493)2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Alarcón Rojas CA, Alvarez-Bañuelos MT,
Morales-Romero J, Suárez-Díaz H, Hernández-Fonseca JC and
Contreras-Alarcón G: Breast cancer: Metastasis, molecular subtypes,
and overweight and obesity in Veracruz Mexico. Clin Breast Cancer.
19:e166–e171. 2019.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Maroni P: Leptin, adiponectin, and Sam68
in bone metastasis from breast cancer. Int J Mol Sci.
21(1051)2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Christodoulatos GS, Spyrou N, Kadillari J,
Psallida S and Dalamaga M: The role of adipokines in breast cancer:
Current evidence and perspectives. Curr Obes Rep. 8:413–433.
2019.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Panno ML, Naimo GD, Spina E, Andò S and
Mauro L: Different molecular signaling sustaining adiponectin
action in breast cancer. Curr Opin Pharmacol. 31:1–7.
2016.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Starek-Świechowicz B, Budziszewska B and
Starek A: Endogenous estrogens-breast cancer and chemoprevention.
Pharmacol Rep. 73:1497–1512. 2021.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Bhardwaj P, Au CC, Benito-Martin A,
Ladumor H, Oshchepkova S, Moges R and Brown KA: Estrogens and
breast cancer: Mechanisms involved in obesity-related development,
growth and progression. J Steroid Biochem Mol Biol. 189:161–170.
2019.PubMed/NCBI View Article : Google Scholar
|
|
51
|
de Klein B, Eickhoff N and Zwart W: The
emerging regulatory interface between DNA repair and steroid
hormone receptors in cancer. Trends Mol Med. 31:718–730.
2025.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Do QT, Tzeng SF, Wang CY, Wu CH, Kafeenah
H and Chen SH: Genome-wide mapping and quantification of DNA damage
induced by catechol estrogens using Click-Probe-Seq and
LC-MS2. Commun Biol. 8(357)2025.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Li F and Gao Z: Obesity, chronic breast
inflammation and carcinogenesis: Molecular pathways and clinical
implications (review). Int J Oncol. 68(12)2026.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Purohit A, Duncan LJ, Wang DY, Coldham NG,
Ghilchik MW and Reed MJ: Paracrine control of oestrogen production
in breast cancer. Endocrine Rel Cancer. 4:323–330. 1997.
|
|
55
|
Mohammed Bakheet M, Mohssin Ali H and
Jalil Talab T: Evaluation of some proinflammatory cytokines and
biochemical parameters in pre and postmenopausal breast cancer
women. Cytokine. 179(156632)2024.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Kakkat S, Suman P, Turbat-Herrera EA,
Singh S, Chakroborty D and Sarkar C: Exploring the multifaceted
role of obesity in breast cancer progression. Front Cell Dev Biol.
12(1408844)2024.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Gamba G, Colonetti T, Uggioni MLR, Elibio
LU, Balbinot EL, Heinzen R, Macedo ACL, Grande AJ and da Rosa MI:
Gut microbiota and breast cancer: Systematic review and
meta-analysis. Breast Cancer. 32:242–257. 2025.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Teng NMY, Price CA, McKee AM, Hall LJ and
Robinson SD: Exploring the impact of gut microbiota and diet on
breast cancer risk and progression. Int J Cancer. 149:494–504.
2021.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Lv R, Wang D, Wang T, Li R and Zhuang A:
Causality between gut microbiota, immune cells, and breast cancer:
Mendelian randomization analysis. Medicine (Baltimore).
103(e40815)2024.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Anwer EKE, Ajagbe M, Sherif M, Musaibah
AS, Mahmoud S, ElBanbi A and Abdelnaser A: Gut microbiota secondary
metabolites: Key roles in GI tract cancers and infectious diseases.
Biomedicines. 13(100)2025.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Liu J, Shi J, Zhang T, Chen M, Li Z, Lu C
and Wang F: Serum and fecal metabolite profiles linking with gut
microbiome in triple-negative breast cancer patients. Breast Cancer
(Auckl). 18(11782234241285645)2024.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Sarfraz H, Czerniecki BJ, Stankiewicz K,
Jaglal MV, Jain S, Yadav H, Liu M, Shukla R, Kumar V, Alhomsi M, et
al: Evaluating gut microbiome as a biomarker of pathological
complete response in patients with early locally advanced triple
negative breast cancer (LA TNBC): A pilot study. J Clin Oncol. 42
(16 Suppl)(S593)2024.
|
|
63
|
Practice Committee of the American Society
for Reproductive Medicine. Electronic address: asrm@asrm.org;
Practice Committee of the American Society for Reproductive
Medicine. Obesity and reproduction: A committee opinion. Fertil
Steril. 116:1266–1285. 2021.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Renehan AG: Obesity and cancer in
Asia-Pacific populations. Lancet Oncol. 11:704–705. 2010.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Huang Z, Hankinson SE, Colditz GA,
Stampfer MJ, Hunter DJ, Manson JE, Hennekens CH, Rosner B, Speizer
FE and Willett WC: Dual effects of weight and weight gain on breast
cancer risk. JAMA. 278:1407–1411. 1997.PubMed/NCBI
|
|
66
|
Kaaks R, Van Noord PA, Den Tonkelaar I,
Peeters PH, Riboli E and Grobbee DE: Breast-cancer incidence in
relation to height, weight and body-fat distribution in the Dutch
‘DOM’ cohort. Int J Cancer. 76:647–651. 1998.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Lahmann PH, Hoffmann K, Allen N, van Gils
CH, Khaw KT, Tehard B, Berrino F, Tjønneland A, Bigaard J, Olsen A,
et al: Body size and breast cancer risk: Findings from the European
prospective investigation into cancer and nutrition (EPIC). Int J
Cancer. 111:762–771. 2004.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Karimi M, Asbaghi O, Hooshmand F, Aghayan
AH, Shariati AA, Kazemi K, Amirpour M, Davoodi SH and Larijani B:
Adherence to mediterranean diet and breast cancer risk: A
meta-analysis of prospective observational studies. Health Sci Rep.
8(e70736)2025.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Bonanni B, Puntoni M, Cazzaniga M, Pruneri
G, Serrano D, Guerrieri-Gonzaga A, Gennari A, Trabacca MS,
Galimberti V, Veronesi P, et al: Dual effect of metformin on breast
cancer proliferation in a randomized presurgical trial. J Clin
Oncol. 30:2593–2600. 2012.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Tapia E, Villa-Guillen DE, Chalasani P,
Centuori S, Roe DJ, Guillen-Rodriguez J, Huang C, Galons JP,
Thomson CA, Altbach M, et al: A randomized controlled trial of
metformin in women with components of metabolic syndrome:
Intervention feasibility and effects on adiposity and breast
density. Breast Cancer Res Treat. 190:69–78. 2021.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Butovskaya M, Sorokowska A, Karwowski M,
Sabiniewicz A, Fedenok J, Dronova D, Negasheva M, Selivanova E and
Sorokowski P: Waist-to-hip ratio, body-mass index, age and number
of children in seven traditional societies. Sci Rep.
7(1622)2017.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Dossus L, Rinaldi S, Biessy C, Hernandez
M, Lajous M, Monge A, Ortiz-Panozo E, Yunes E, Lopez-Ridaura R,
Torres-Mejía G and Romieu I: Circulating leptin and adiponectin,
and breast density in premenopausal Mexican women: The Mexican
Teachers' Cohort. Cancer Causes Control. 28:939–946.
2017.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Lee SJ, Liu J, Yao J, Kanarek A, Summers
RM and Pickhardt PJ: Fully automated segmentation and
quantification of visceral and subcutaneous fat at abdominal CT:
Application to a longitudinal adult screening cohort. Br J Radiol.
91(20170968)2018.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Kaess BM, Pedley A, Massaro JM, Murabito
J, Hoffmann U and Fox CS: The ratio of visceral to subcutaneous
fat, a metric of body fat distribution, is a unique correlate of
cardiometabolic risk. Diabetologia. 55:2622–2630. 2012.PubMed/NCBI View Article : Google Scholar
|
